SciELO - Scientific Electronic Library Online

 
vol.30 número1Niveles de antitoxina tetánica y diftérica relacionadas con el alelo HLA-B27 en pacientes cubanos con uveítis anterior no infecciosaExpresión de la proteína recombinante PreS2-S del antígeno de superficie del virus de la hepatitis B en Pichia pastoris índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Articulo

Indicadores

  • No hay articulos citadosCitado por SciELO

Links relacionados

  • No hay articulos similaresSimilares en SciELO

Compartir


Vaccimonitor

versión On-line ISSN 1025-0298

Resumen

CHUY-RAMON, Lianet; ZUMALACARREGUI-DE CARDENAS, Lourdes; LOBAINA-RODRIGUEZ, Tamara  y  PEREZ-DE LA CONCEPCION, Humberto. Improvement of the aseptic filling process for the production of recombinant hepatitis vaccine. Vaccimonitor [online]. 2021, vol.30, n.1, pp. 18-26.  Epub 01-Feb-2021. ISSN 1025-0298.

National Center for Biopreparations must increase the production of the recombinant hepatitis B vaccine because of its growing demand. In order to fulfill this challenge, the aseptic filling process required an investment. This work, presents the selection of the new filling machine and the economic indicators that support the investment. Inversion cost is recovered in the fourth year with a profit equivalent to $2,655,300. After the investment, the performance of the new machine was compared with the previous one. Volume dispensed per vial, filling speed, operational performance, major defects detected in filling batches, average filling time for a batch, production cost and payments to customers due to rejected products were compared. The control of the volume dispensed per vial is more accurate, reducing product losses. The filling speed increases 1.7 times compared to the previous machine. Operational performance increases by 13.63%. Product rejections are reduced by 40,897 vials, saving $24,538 for the 73 batches. Electricity consumption diminished, saving $14,718 monthly. The unit cost of the filling process decreases by $0.0648/vial.

Palabras clave : vaccines; hepatitis B; technology.

        · resumen en Español     · texto en Español     · Español ( pdf )